We are live on ! Find out more
JSPR icon

Jasper Therapeutics

22 hedge funds and large institutions have $69.6M invested in Jasper Therapeutics in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,569% more call options, than puts

Call options by funds: $801K | Put options by funds: $48K

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

2.3% less ownership

Funds ownership: 57.21% → 54.9% (-2.3%)

4% less funds holding

Funds holding: 23 → 22 (-1)

46% less capital inflows, than outflows

Capital inflows: $3.53M | Capital outflows: $6.51M

71% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 7

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.35%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
6
Increased
2
Reduced
7
Closed
6
Calls
$801K
Puts
$48K
Net Calls
+$753K
Net Calls Change
-$997K

JSPR Hedge Fund Activity: Q1 2022 in Review

22 of the 6,366 institutional investors tracked by Wall St. Rank reported a position in Jasper Therapeutics (JSPR) for Q1 2022, worth a combined $69.6M — down 57% from $161M a quarter earlier.

Fund positioning in JSPR was balanced in Q1 2022: 6 funds opened new positions, 6 closed out, 2 added to existing stakes and 7 trimmed.

The largest buyer was Sectoral Asset Management, opening a new position worth an estimated $3.04M. The largest seller was Federated Hermes, cutting an estimated $4.3M.

  • 22 institutional investors held Jasper Therapeutics (JSPR) as of Q1 2022, down from 23 in Q4 2021.
  • Funds reported $69.6M of Jasper Therapeutics stock for Q1 2022, down 57% quarter-over-quarter.
  • 6 funds opened new Jasper Therapeutics positions in Q1 2022 and 6 closed out, a net change of 0 holders.
  • The largest Jasper Therapeutics buyer in Q1 2022 was Sectoral Asset Management, an estimated $3.04M added.
  • The largest Jasper Therapeutics seller in Q1 2022 was Federated Hermes, an estimated $4.3M sold.

Based on aggregated 13F filings for Q1 2022.